rs1017141110

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_000551.4(VHL):​c.27C>A​(p.Asp9Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000724 in 1,533,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D9A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000078 ( 0 hom. )

Consequence

VHL
NM_000551.4 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: -0.0920

Publications

3 publications found
Variant links:
Genes affected
VHL (HGNC:12687): (von Hippel-Lindau tumor suppressor) This gene encodes a component of a ubiquitination complex. The encoded protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. In addition to oxygen-related gene expression, this protein plays a role in many other cellular processes including cilia formation, cytokine signaling, regulation of senescence, and formation of the extracellular matrix. Variants of this gene are associated with von Hippel-Lindau syndrome, pheochromocytoma, erythrocytosis, renal cell carcinoma, and cerebellar hemangioblastoma. [provided by RefSeq, Jun 2022]
VHL Gene-Disease associations (from GenCC):
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • von Hippel-Lindau disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • renal cell carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • autosomal recessive secondary polycythemia not associated with VHL gene
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics
  • Chuvash polycythemia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.060362637).
BP6
Variant 3-10141874-C-A is Benign according to our data. Variant chr3-10141874-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 411975.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000551.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VHL
NM_000551.4
MANE Select
c.27C>Ap.Asp9Glu
missense
Exon 1 of 3NP_000542.1
VHL
NM_001354723.2
c.27C>Ap.Asp9Glu
missense
Exon 1 of 3NP_001341652.1
VHL
NM_198156.3
c.27C>Ap.Asp9Glu
missense
Exon 1 of 2NP_937799.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VHL
ENST00000256474.3
TSL:1 MANE Select
c.27C>Ap.Asp9Glu
missense
Exon 1 of 3ENSP00000256474.3
VHL
ENST00000345392.3
TSL:1
c.27C>Ap.Asp9Glu
missense
Exon 1 of 2ENSP00000344757.2
VHL
ENST00000477538.2
TSL:1
n.73C>A
non_coding_transcript_exon
Exon 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152204
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000284
AC:
4
AN:
140648
AF XY:
0.0000134
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000435
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000576
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000782
AC:
108
AN:
1381762
Hom.:
0
Cov.:
32
AF XY:
0.0000662
AC XY:
45
AN XY:
679490
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30900
American (AMR)
AF:
0.0000294
AC:
1
AN:
34044
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24432
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35314
South Asian (SAS)
AF:
0.00
AC:
0
AN:
77602
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48008
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4014
European-Non Finnish (NFE)
AF:
0.0000981
AC:
105
AN:
1070432
Other (OTH)
AF:
0.0000351
AC:
2
AN:
57016
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152204
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41450
American (AMR)
AF:
0.00
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68036
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.558
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

ClinVar submissions as Germline

Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
1
-
not provided (1)
-
1
-
Von Hippel-Lindau syndrome (1)
-
1
-
Von Hippel-Lindau syndrome;C1837915:Chuvash polycythemia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
0.20
DANN
Benign
0.62
DEOGEN2
Benign
0.27
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.043
N
LIST_S2
Benign
0.38
T
M_CAP
Benign
0.050
D
MetaRNN
Benign
0.060
T
MetaSVM
Benign
-0.82
T
MutationAssessor
Benign
-0.34
N
PhyloP100
-0.092
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-0.14
N
REVEL
Benign
0.13
Sift
Benign
0.49
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.053
MVP
0.92
MPC
0.67
ClinPred
0.028
T
GERP RS
-3.5
PromoterAI
-0.042
Neutral
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
2.7
Varity_R
0.10
gMVP
0.11
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1017141110; hg19: chr3-10183558; API